Harold Marcotte

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: GENES AND IMMUNITY. 2024;25(2):158-167
Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines
Garcia-Vega M; Wan H; Resendiz-Sandoval M; Hinojosa-Trujillo D; Valenzuela O; Mata-Haro V; Dehesa-Canseco F; Solis-Hernandez M; Marcotte H; Pan-Hammarstrom Q; Hernandez J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024;121(3):e2315354120
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages
Marcotte H; Cao Y; Zuo F; Simonelli L; Sammartino JC; Pedotti M; Sun R; Cassaniti I; Hagbom M; Piralla A; Yang J; Du L; Percivalle E; Bertoglio F; Schubert M; Abolhassani H; Sherina N; Guerra C; Borte S; Rezaei N; Kumagai-Braesch M; Xue Y; Su C; Yan Q; He P; Groenwall C; Klareskog L; Calzolai L; Cavalli A; Wang Q; Robbiani DF; Hust M; Shi Z; Feng L; Svensson L; Chen L; Bao L; Baldanti F; Xiao J; Qin C; Hammarstrom L; Yang X; Varani L; Xie XS; Pan-Hammarstrom Q
Article: NATURE COMMUNICATIONS. 2023;14(1):6527
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
Hueting D; Schriever K; Sun R; Vlachiotis S; Zuo F; Du L; Persson H; Hofstrom C; Ohlin M; Wallden K; Buggert M; Hammarstrom L; Marcotte H; Pan-Hammarstroem Q; Andrell J; Syren P-O
Article: ISCIENCE. 2023;26(4):106562
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
Garcia-Vega M; Melgoza-Gonzalez EA; Hernandez-Valenzuela S; Hinojosa-Trujillo D; Resendiz-Sandoval M; Llamas-Covarrubias MA; Loza-Lopez M; Valenzuela O; Soto-Gaxiola A; Hernandez-Onate MA; Mata-Haro V; Cassaniti I; Sammartino JC; Ferrari A; Simonelli L; Pedotti M; Sun R; Zuo F; Baldanti F; Varani L; Marcotte H; Pan-Hammarstrom Q; Hernandez J
Article: SCIENCE IMMUNOLOGY. 2023;8(81):eade0958
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Rincon TC; Fava T; Podesvova L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Honig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Clabbattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarstroem Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
Article: PHARMACEUTICS. 2022;15(1):63
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Yuki Y; Zuo F; Kurokawa S; Uchida Y; Sato S; Sakon N; Hammarstroem L; Kiyono H; Marcotte H
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;150(5):1059-1073
Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
Abolhassani H; Delavari S; Landegren N; Shokri S; Bastard P; Du L; Zuo F; Hajebi R; Abolnezhadian F; Iranparast S; Modaresi M; Vosughimotlagh A; Salami F; Aranda-Guillen M; Cobat A; Marcotte H; Zhang S-Y; Zhang Q; Rezaei N; Casanova J-L; Kampe O; Hammarstrom L; Pan-Hammarstrom Q
Article: NATURE COMMUNICATIONS. 2022;13(1):2670
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Cassaniti I; Wang Y; Sammartino JC; Sun R; Vlachiotis S; Bergami F; Kumagai-Braesch M; Andrell J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2022;42(3):471-483
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
Abolhassani H; Landegren N; Bastard P; Materna M; Modaresi M; Du L; Aranda-Guillen M; Sardh F; Zuo F; Zhang P; Marcotte H; Marr N; Khan T; Ata M; Al-Ali F; Pescarmona R; Belot A; Beziat V; Zhang Q; Casanova J-L; Kampe O; Zhang S-Y; Hammarstrom L; Pan-Hammarstrom Q
Article: BMC MEDICINE. 2022;20(1):102
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milosevic M; Wenzel EV; Krstanovic F; Polten S; Pribanic-Matesic M; Brizic I; Baldanti F; Hammarstrom L; Duebel S; Sustic A; Marcotte H; Strengert M; Protic A; Piralla A; Pan-Hammarstroem Q; Cicin-Sain L; Hust M
Article: ISCIENCE. 2022;25(2):103743
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte H; Piralla A; Zuo F; Du L; Cassaniti I; Wan H; Kumagai-Braesh M; Andrell J; Percivalle E; Sammartino JC; Wang Y; Vlachiotis S; Attevall J; Bergami F; Ferrari A; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Asperges E; Bruno R; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Calzolai L; Varani L; Hust M; Xue Y; Hammarstrom L; Baldanti F; Pan-Hammarstrom Q
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2022;42(1):1-9
X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
Abolhassani H; Vosughimotlagh A; Asano T; Landegren N; Boisson B; Delavari S; Bastard P; Aranda-Guillen M; Wang Y; Zuo F; Sardh F; Marcotte H; Du L; Zhang S-Y; Zhang Q; Rezaei N; Kampe O; Casanova J-L; Hammarstrom L; Pan-Hammarstrom Q
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(1):65-75.e8
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults
Bjorkander S; Du L; Zuo F; Ekstrom S; Wang Y; Wan H; Sherina N; Schoutens L; Andrell J; Andersson N; Georgelis A; Bergstrom A; Marcotte H; Kull I; Hammarstrom L; Melen E; Pan-Hammarstrom Q
Article: MED. 2021;2(3):281-295.e4
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection
Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andrell J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarstrom L; Baldanti F; Marcotte H; Pan-Hammarstrom Q
Article: VACCINES. 2020;8(4):E758-758
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
Kalusche S; Vanshylla K; Kleipass F; Gruell H; Muller B; Zeng Z; Koch K; Stein S; Marcotte H; Klein F; Dietrich U
Article: JOURNAL OF INFECTIOUS DISEASES. 2020;222(3):470-478
A Heterodimeric Antibody Fragment for Passive Immunotherapy Against Norovirus Infection
Yuki Y; Kurokawa S; Sato S; Sasou A; Matsumoto N; Suzuki A; Sakon N; Goda Y; Takeyama N; Miyoshi T; Marcotte H; Tanaka T; Hammarstrom L; Kiyono H
Article: CLINICAL GENETICS. 2020;97(6):844-856
Clinical implications of experimental analyses of AID function on predictive computational tools: Challenge of missense variants
Abolhassani H; Marcotte H; Fang M; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2019;85(19):e00800-e00819
Putative Adhesion Factors in Vaginal Lactobacillus gasseri DSM 14869: Functional Characterization
Zeng Z; Zu F; Marcotte H
Article: BMC INFECTIOUS DISEASES. 2019;19(1):824
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
Article: ACS SYNTHETIC BIOLOGY. 2019;8(8):1723-1729
Inducible Plasmid Self-Destruction (IPSD) Assisted Genome Engineering in Lactobacilli and Bifidobacteria
Zuo F; Zeng Z; Hammarstrom L; Marcotte H
Article: MICROBIOLOGICAL RESEARCH. 2017;205:88-98
Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L-gasseri DSM 14869 contained in the EcoVag® probiotic vaginal capsules
Marcotte H; Andersen KK; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Bronstad G; Hammarstrom L
Article: MICROBIAL CELL FACTORIES. 2017;16(1):148
Lactobacillus delivery of bioactive interleukin-22
Lin Y; Krogh-Andersen K; Hammarstrom L; Marcotte H
Article: SCIENTIFIC REPORTS. 2016;6:30171
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus
Gunaydin G; Yu S; Graslund T; Hammarstrom L; Marcotte H
Article: INFECTION AND IMMUNITY. 2016;84(2):395-406
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar R-H; Mikelsaar M; Verrips T; Hammarstrom L; Marcotte H
Article: PLOS ONE. 2016;11(9):e0162733
Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats
Lin Y; Krogh-Andersen K; Pelletier J; Marcotte H; Ostenson C-G; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2015;81(17):5784-5793
An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface
Alvarez B; Krogh-Andersen K; Tellgren-Roth C; Martinez N; Guenaydin G; Lin Y; Cruz Martin M; Alvarez MA; Hammarstroem L; Marcotte H
Article: BMC INFECTIOUS DISEASES. 2015;15:255
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection
Pendharkar S; Brandsborg E; Hammarstrom L; Marcotte H; Larsson P-G
Article: VACCINE. 2014;32(4):470-477
Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model
Gunaydin G; Zhang R; Hammarstroem L; Marcotte H
Article: PLOS ONE. 2014;9(4):e96409
Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem
Gunaydin G; Alvarez B; Lin Y; Hammarstroem L; Marcotte H
Article: JOURNAL OF CLINICAL INVESTIGATION. 2013;123(9):3829-3838
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection
Tokuhara D; Alvarez B; Mejima M; Hiroiwa T; Takahashi Y; Kurokawa S; Kuroda M; Oyama M; Kozuka-Hata H; Nochi T; Sagara H; Aladin F; Marcotte H; Frenken LGJ; Iturriza-Gomara M; Kiyono H; Hammarstrom L; Yuki Y
Article: BMC INFECTIOUS DISEASES. 2013;13:43
Identification and characterisation of vaginal lactobacilli from South African women
Pendharkar S; Magopane T; Larsson P-G; de Bruyn G; Gray GE; Hammarstrom L; Marcotte H
Article: BMC BIOTECHNOLOGY. 2011;11:126
In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli
Andersen KK; Marcotte H; Alvarez B; Boyaka PN; Hammarstrom L
Article: BMC INFECTIOUS DISEASES. 2011;11:223
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses
Larsson P-G; Brandsborg E; Forsum U; Pendharkar S; Andersen KK; Nasic S; Hammarstrom L; Marcotte H
Article: FUTURE MICROBIOLOGY. 2011;6(5):583-593
Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
Pant N; Marcotte H; Hermans P; Bezemer S; Frenken L; Johansen K; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2011;77(6):2174-2179
Integrative Expression System for Delivery of Antibody Fragments by Lactobacilli
Cruz Martin M; Pant N; Ladero V; Gunaydin G; Andersen KK; Alvarez B; Martinez N; Alvarez MA; Hammarstrom L; Marcotte H
Article: CURRENT MICROBIOLOGY. 2010;61(6):560-566
Screening and Evaluation of Human Intestinal Lactobacilli for the Development of Novel Gastrointestinal Probiotics
Koll P; Maendar R; Smidt I; Huett P; Truusalu K; Mikelsaar R-H; Shchepetova J; Krogh-Andersen K; Marcotte H; Hammarstrom L; Mikelsaar M
Article: FUTURE VIROLOGY. 2008;3(4):327-341
Engineered lactobody-producing lactobacilli:: a novel form of therapy against rotavirus infection
Marcotte H; Pant N; Hammarstrom L
Article: MOLECULAR ORAL MICROBIOLOGY. 2008;23(2):139-147
Characterization of oral lactobacilli as potential probiotics for oral health
Koll P; Maendar R; Marcotte H; Leibur E; Mikelsaar M; Hammarstro L
Article: BMC MICROBIOLOGY. 2007;7:86
Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies
Pant N; Marcotte H; Bruessow H; Svensson L; Hammarstrom L
Article: BMC BIOTECHNOLOGY. 2007;7:58
Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages
Hultberg A; Tremblay DM; de Haard H; Verrips T; Moineau S; Hammarstoem L; Marcotte H
Article: JOURNAL OF INFECTIOUS DISEASES. 2006;194(11):1580-1588
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
Pant N; Hultberg A; Zhao Y; Svensson L; Pan-Hammarstrom Q; Johansen K; Pouwels PH; Ruggeri FM; Hermans P; Frenken L; Boren T; Marcotte H; Hammarstrom L
Article: APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. 2006;72(4):732-737
Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries
Kruger C; Hultberg A; Marcotte H; Hermans P; Bezemer S; Frenken LGJ; Hammarstrom L
Article: JOURNAL OF APPLIED MICROBIOLOGY. 2006;100(2):256-263
Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus
Marcotte H; Koll-Klais P; Hultberg A; Zhao Y; Gmür R; Mändar R; Mikelsaar M; Hammarström L
Article: MOLECULAR ORAL MICROBIOLOGY. 2005;20(6):354-361
Oral lactobacilli in chronic periodontitis and periodontal health:: species composition and antimicrobial activity
Koll-Klais P; Mändar R; Leibur E; Marcotte H; Hammarström L; Mikelsaar M
Article: MOLECULAR BIOTECHNOLOGY. 2005;31(3):221-231
Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans
Krüger C; Hultberg A; van Dollenweerd C; Marcotte H; Hammarström L
Article: INFECTION AND IMMUNITY. 2004;72(5):2753-2761
Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RWF; Wells JM
Article: JOURNAL OF APPLIED MICROBIOLOGY. 2004;97(4):749-756
The aggregation-promoting factor of Lactobacillus crispatus M247 and its genetic locus
Marcotte H; Ferrari S; Cesena C; Hammarström L; Morelli L; Pozzi G; Oggioni MR
Article: NATURE BIOTECHNOLOGY. 2002;20(7):702-706
In situ delivery of passive immunity by lactobacilli producing single-chain antibodies
Krüger C; Hu YZ; Pan Q; Marcotte H; Hultberg A; Delwar D; van Dalen PJ; Pouwels PH; Leer RJ; Kelly CG; van Dollenweerd C; Ma JK; Hammarström L
Article: MICROBIAL PATHOGENESIS. 2001;30(4):229-235
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii.
Ricci S; Medaglini D; Marcotte H; Olsén A; Pozzi G; Björck L
Article: VACCINE. 2001;19(15-16):1931-1939
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Article: MOLECULAR ORAL MICROBIOLOGY. 1997;12(3):141-147
Comparison of the indigenous oral microbiota and immunoglobulin responses of athymic (nu/nu) and euthymic (nu/+) mice.
Marcotte H; Lavoie MC
Article: INFECTION AND IMMUNITY. 1996;64(11):4694-4699
No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice.
Marcotte H; Lavoie MC
Article: JOURNAL OF INFECTIOUS DISEASES. 1996;173(4):1034-1037
Pneumocystis carinii infection in transgenic B cell-deficient mice.
Marcotte H; Levesque D; Delanay K; Bourgeault A; de la Durantaye R; Brochu S; Lavoie MC
Article: MOLECULAR ORAL MICROBIOLOGY. 1995;10(3):168-174
Colonization of the oral cavity of mice by an unidentified streptococcus.
Marcotte H; Rodrigue L; Coulombe C; Goyette N; Lavoie MC
Article: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1995;371B:1173-1176
Immunization against the oral indigenous bacteria of the BALB/c mouse.
Marcotte H; Rodrigue L; Gamache M; Lavoie MC
Journal article: JOURNAL OF IMMUNOASSAY. 1993;14(1-2):63-81
Evaluation of mouse salivary IgA directed against indigenous oral bacteria.
Marcotte H; Lavoie MC
Visa fler

Alla övriga publikationer

Editorial comment: LANCET INFECTIOUS DISEASES. 2024;24(1):e7-e9
Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86
Zuo F; Cao Y; Sun R; Yisimayi A; Du L; Bertoglio F; Schubert M; Guerra C; Cavalli A; Hust M; Robbiani DF; Abolhassani H; Xie XS; Hammarstroem L; Marcotte H; Pan-Hammarstroem Q
Letter: LANCET REGIONAL HEALTH-WESTERN PACIFIC. 2023;33:100762
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
Zuo F; Sun R; Abolhassani H; Du L; Wang Y; Vlachiotis S; Bertoglio F; Schubert M; Rezaei N; Chavoshzadeh Z; Guerra C; Cavalli A; Andrell J; Kumagai-Braesch M; Xue Y; Cao Y; Hust M; Robbiani DF; Xie XS; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Preprint: BIORXIV. 2022;BIORXIV
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.
Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Rincón TC; Fava T; Podešvová L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Hönig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Ciabattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarström Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(21):e55
Mucosal IgA against SARS-CoV-2 Omicron Infection
Zuo F; Marcotte H; Hammarstrom L; Pan-Hammarstrom Q
Editorial comment: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2022;7(1):294
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Marcotte H; Hammarstrom L; Pan-Hammarstrom Q
Review: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. 2021;21(6):553-558
Antibody therapy for COVID-19
Hammarstrom L; Marcotte H; Piralla A; Baldanti F; Pan-Hammarstrom Q
Review: CURRENT OPINION IN BIOTECHNOLOGY. 2021;70:75-82
Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing
Zuo F; Marcotte H
Review: BIOTECHNOLOGY ADVANCES. 2020;45:107654
Engineer probiotic bifidobacteria for food and biomedical applications - Current status and future prospective
Zuo F; Chen S; Marcotte H
Editorial comment: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;146(1):58-60
Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective
Hammarstrom L; Abolhassani H; Baldanti F; Marcotte H; Pan-Hammarstrom Q
Review: CURRENT MICROBIOLOGY. 2019;76(6):774-782
Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics
Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
Review: BENEFICIAL MICROBES. 2018;9(1):3-20
Our gut microbiota: a long walk to homeostasis
Dicks LMT; Geldenhuys J; Mikkelsen LS; Brandsborg E; Marcotte H
Book chapter: VIRAL GASTROENTERITIS. 2016;p. 47-71
Chapter 1.3 Immunodeficiencies: Significance for Gastrointestinal Disease
Marcotte H; Hammarström L
Book chapter: MUCOSAL IMMUNOLOGY. 2015;p. 1403-1434
Chapter 71 Passive Immunization Toward Magic Bullets
Marcotte H; Hammarström L
Published conference paper: BENEFICIAL MICROBES. 2011;2(1):79-90
Safety and persistence of orally administered human Lactobacillus sp strains in healthy adults
Huett P; Koll P; Stsepetova J; Alvarez B; Maendar R; Krogh-Andersen K; Marcotte H; Hammarstroem L; Mikelsaar M
Review: MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. 1998;62(1):71-109
Oral microbial ecology and the role of salivary immunoglobulin A.
Marcotte H; Lavoie MC

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI